title: Gene Electrotransfer of Canine Interleukin 12 into Canine Melanoma Cell Lines.
abstract: A gene electrotransfer (GET) of interleukin 12 (IL-12) had already given good results when treating tumors in human and veterinary clinical trials. So far, plasmids used in veterinary clinical studies encoded a human or a feline IL-12 and an ampicillin resistance gene, which is not recommended by the regulatory agencies to be used in clinical trials. Therefore, the aim of the current study was to construct the plasmid encoding a canine IL-12 with kanamycin antibiotic resistance gene that could be used in veterinary clinical oncology. The validation of the newly constructed plasmid was carried out on canine malignant melanoma cells, which have not been used in GET studies so far, and on human malignant melanoma cells. Canine and human malignant melanoma cell lines were transfected with plasmid encoding enhanced green fluorescence protein at different pulse parameter conditions to determine the transfection efficiency and cell survival. The IL-12 expression of the most suitable conditions for GET of the plasmid encoding canine IL-12 was determined at mRNA level by the qRT-PCR and at protein level with the ELISpot assay. The obtained results showed that the newly constructed plasmid encoding canine IL-12 had similar or even higher expression capacity than the plasmid encoding human IL-12. Therefore, it represents a promising therapeutic plasmid for further IL-12 gene therapy in clinical studies for spontaneous canine tumors. Additionally, it also meets the main regulatory agencies' (FDA and EMA) criteria.
authors.affiliation: Department of Experimental Oncology, Institute of Oncology Ljubljana, Zaloska 2, 1000, Ljubljana, Slovenia.
authors.forename: Ursa
authors.initials: U
authors.lastname: Lampreht
authors.forename: Urska
authors.initials: U
authors.lastname: Kamensek
authors.forename: Monika
authors.initials: M
authors.lastname: Stimac
authors.forename: Gregor
authors.initials: G
authors.lastname: Sersa
authors.forename: Natasa
authors.initials: N
authors.lastname: Tozon
authors.forename: Masa
authors.initials: M
authors.lastname: Bosnjak
authors.forename: Andreja
authors.initials: A
authors.lastname: Brozic
authors.forename: Geraldo Gileno
authors.initials: GG
authors.lastname: de Sá Oliveira
authors.forename: Takayuki
authors.initials: T
authors.lastname: Nakagawa
authors.forename: Kohei
authors.initials: K
authors.lastname: Saeki
authors.forename: Maja
authors.initials: M
authors.lastname: Cemazar
mesh_terms: D000818:Animals; D002415:Cats; D002470:Cell Survival; D004285:Dogs; D018274:Electroporation / Q000379:methods*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D006801:Humans; D018664:Interleukin-12 / Q000008:administration & dosage* / Q000378:metabolism; D008545:Melanoma / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D010957:Plasmids / Q000008:administration & dosage*; D014162:Transfection / Q000379:methods*; D014407:Tumor Cells, Cultured
chemical_list: C485184:enhanced green fluorescent protein; D049452:Green Fluorescent Proteins; D018664:Interleukin-12
references.citation: Crit Rev Oncol Hematol. 2013 Oct;88(1):187-97
references.pmid: 23561333
references.citation: Pigment Cell Melanoma Res. 2014 Jan;27(1):90-102
references.pmid: 24112648
references.citation: Hum Gene Ther Methods. 2013 Oct;24(5):289-97
references.pmid: 23931158
references.citation: J Clin Oncol. 2008 Dec 20;26(36):5896-903
references.pmid: 19029422
references.citation: Eur J Surg Oncol. 2013 Jan;39(1):4-16
references.pmid: 22980492
references.citation: Clin Rev Allergy Immunol. 2003 Jun;24(3):201-20
references.pmid: 12721392
references.citation: Methods Mol Biol. 2008;423:319-25
references.pmid: 18370210
references.citation: Nat Rev Genet. 2012 Mar 13;13(4):227-32
references.pmid: 22411467
references.citation: J Vet Med Sci. 2004 Nov;66(11):1437-40
references.pmid: 15585963
references.citation: J Cancer Res Ther. 2012 Jan-Mar;8(1):80-5
references.pmid: 22531519
references.citation: Radiol Oncol. 2013 Oct 08;47(4):366-9
references.pmid: 24294181
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: BMC Cancer. 2004 Nov 16;4:81
references.pmid: 15546484
references.citation: Cancer Gene Ther. 2010 Aug;17(8):571-8
references.pmid: 20414325
references.citation: Cytokine. 1998 Apr;10(4):241-8
references.pmid: 9617567
references.citation: Radiol Oncol. 2011 Mar;45(1):31-9
references.pmid: 22933932
references.citation: Biochim Biophys Acta. 2000 Aug 25;1467(2):362-8
references.pmid: 11030594
references.citation: Int J Cancer. 2009 Aug 1;125(3):698-707
references.pmid: 19431145
references.citation: J Membr Biol. 2012 Dec;245(12):789-95
references.pmid: 22836669
references.citation: Nature. 2011 May 19;473(7347):337-42
references.pmid: 21593866
references.citation: Hum Gene Ther Clin Dev. 2013 Sep;24(3):99-107
references.pmid: 23980876
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):978-81
references.pmid: 20332253
references.citation: Biophys J. 1998 Sep;75(3):1415-23
references.pmid: 9726943
references.citation: J Feline Med Surg. 2014 Apr;16(4):291-9
references.pmid: 24127456
references.citation: J Membr Biol. 2013 Oct;246(10):783-91
references.pmid: 23652810
references.citation: J Gene Med. 2004 Feb;6 Suppl 1:S11-23
references.pmid: 14978747
references.citation: Trends Biotechnol. 2013 Sep;31(9):539-47
references.pmid: 23830144
references.citation: Clin Cancer Res. 1997 Mar;3(3):409-17
references.pmid: 9815699
references.citation: J Membr Biol. 2013 Oct;246(10):737-44
references.pmid: 23525583
references.citation: J Membr Biol. 2014 May;247(5):421-8
references.pmid: 24648010
references.citation: Adv Cancer Res. 2007;96:191-212
references.pmid: 17161681
references.citation: Vet Immunol Immunopathol. 2004 Mar;98(1-2):43-8
references.pmid: 15127840
references.citation: Mol Ther. 2011 Nov;19(11):1942-9
references.pmid: 21878901
references.citation: Gene Ther. 2008 Apr;15(7):537-44
references.pmid: 18256695